Cargando…
Alendronate increases BMD at appendicular and axial skeletons in patients with established osteoporosis
BACKGROUND: To identify high-risk patients and provide pharmacological treatment is one of the effective approaches in prevention of osteoporotic fractures. This study investigated the effect of 12-month Alendronate treatment on bone mineral density (BMD) and bone turnover biochemical markers in pos...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885425/ https://www.ncbi.nlm.nih.gov/pubmed/17511887 http://dx.doi.org/10.1186/1749-799X-2-9 |